BR0210473A - Composição compreendendo um inibidor da pde-4 e antagonista do receptor-h1 e seus usos na produção de um medicamento para o tratamento de doenças respiratórias - Google Patents

Composição compreendendo um inibidor da pde-4 e antagonista do receptor-h1 e seus usos na produção de um medicamento para o tratamento de doenças respiratórias

Info

Publication number
BR0210473A
BR0210473A BR0210473-3A BR0210473A BR0210473A BR 0210473 A BR0210473 A BR 0210473A BR 0210473 A BR0210473 A BR 0210473A BR 0210473 A BR0210473 A BR 0210473A
Authority
BR
Brazil
Prior art keywords
treatment
inhibitor
receptor antagonist
pde
composition
Prior art date
Application number
BR0210473-3A
Other languages
English (en)
Inventor
Richard Graham Knowles
Peter Ward
Anthony Terence Nials
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BR0210473A publication Critical patent/BR0210473A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"COMPOSIçãO COMPREENDENDO UM INIBIDOR DA PDE-4 E ANTAGONISTA DO RECEPTOR-H1 E SEUS USOS NA PRODUçãO DE UM MEDICAMENTO PARA O TRATAMENTO DE DOENçAS RESPIRATóRIAS". A invenção está relacionada ao tratamento de doenças pulmonares, tais como doença pulmonar obstrutiva crónica ou asma pela administração de um inibidor da fosfodiesterase 4 combinada com um antagonista do receptor-H1.
BR0210473-3A 2001-06-20 2002-06-17 Composição compreendendo um inibidor da pde-4 e antagonista do receptor-h1 e seus usos na produção de um medicamento para o tratamento de doenças respiratórias BR0210473A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0115181.0A GB0115181D0 (en) 2001-06-20 2001-06-20 Novel use
PCT/GB2002/002679 WO2003000289A1 (en) 2001-06-20 2002-06-17 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
BR0210473A true BR0210473A (pt) 2004-08-10

Family

ID=9917074

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210473-3A BR0210473A (pt) 2001-06-20 2002-06-17 Composição compreendendo um inibidor da pde-4 e antagonista do receptor-h1 e seus usos na produção de um medicamento para o tratamento de doenças respiratórias

Country Status (19)

Country Link
US (1) US20040176419A1 (pt)
EP (1) EP1404369A1 (pt)
JP (1) JP2005501023A (pt)
KR (1) KR20040029323A (pt)
CN (1) CN1518460A (pt)
AR (1) AR035253A1 (pt)
BR (1) BR0210473A (pt)
CA (1) CA2450758A1 (pt)
CO (1) CO5540290A2 (pt)
CZ (1) CZ20033435A3 (pt)
GB (1) GB0115181D0 (pt)
HU (1) HUP0400222A3 (pt)
IL (1) IL159379A0 (pt)
MX (1) MXPA03011702A (pt)
NO (1) NO20035602D0 (pt)
PL (1) PL367622A1 (pt)
RU (1) RU2004101278A (pt)
WO (1) WO2003000289A1 (pt)
ZA (1) ZA200309587B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
TWI347845B (en) * 2002-03-06 2011-09-01 Nycomed Gmbh Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20060263350A1 (en) * 2003-09-26 2006-11-23 Fairfield Clinical Trials Llc Combination antihistamine medication
EP2218442A1 (en) 2005-11-09 2010-08-18 CombinatoRx, Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US8207188B2 (en) * 2006-04-07 2012-06-26 Michalis Nicolaou Treatment of diseases modulated by a H4 receptor agonist
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
WO2008127975A2 (en) * 2007-04-11 2008-10-23 Alcon Research, Ltd. Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
JP5721722B2 (ja) * 2009-10-01 2015-05-20 アルコン リサーチ， リミテッド オロパタジン組成物およびその使用
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
MX2015010714A (es) 2013-02-19 2016-06-14 Pfizer Compuestos de azabencimidazol.
JP6713982B2 (ja) 2014-07-24 2020-06-24 ファイザー・インク ピラゾロピリミジン化合物
MX2017001565A (es) 2014-08-06 2017-04-27 Pfizer Compuestos de imidazopiridazina.
CN104644584A (zh) * 2015-01-22 2015-05-27 扬子江药业集团有限公司 罗氟司特片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4852561A (en) * 1988-07-27 1989-08-01 Sperry C R Inhalation device
US5990147A (en) * 1997-11-07 1999-11-23 Schering Corporation H3 receptor ligands of the phenyl-alkyl-imidazoles type
IL136461A0 (en) * 1997-12-23 2001-06-14 Schering Corp Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
BR9804993A (pt) * 1998-11-10 2000-06-06 Panacea Biotec Ltd Composição antialérgica e antiinflamatória
US20020052312A1 (en) * 2000-05-30 2002-05-02 Reiss Theodore F. Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists

Also Published As

Publication number Publication date
AR035253A1 (es) 2004-05-05
US20040176419A1 (en) 2004-09-09
CN1518460A (zh) 2004-08-04
GB0115181D0 (en) 2001-08-15
EP1404369A1 (en) 2004-04-07
MXPA03011702A (es) 2004-03-19
IL159379A0 (en) 2004-06-01
HUP0400222A3 (en) 2006-02-28
CO5540290A2 (es) 2005-07-29
ZA200309587B (en) 2005-02-23
WO2003000289A1 (en) 2003-01-03
RU2004101278A (ru) 2005-02-27
NO20035602D0 (no) 2003-12-16
HUP0400222A2 (hu) 2004-07-28
CZ20033435A3 (cs) 2004-08-18
PL367622A1 (en) 2005-03-07
JP2005501023A (ja) 2005-01-13
KR20040029323A (ko) 2004-04-06
CA2450758A1 (en) 2003-01-03

Similar Documents

Publication Publication Date Title
BR0210473A (pt) Composição compreendendo um inibidor da pde-4 e antagonista do receptor-h1 e seus usos na produção de um medicamento para o tratamento de doenças respiratórias
TW200505483A (en) New medicament compositions based on anticholinergically-effective compounds and β-mimetics
BR9915553A (pt) Amidas de ácido antranìlico e seu emprego como medicamento
ECSP024268A (es) Nuevos polvos para inhalacion que contienen tiotropio
BR0209957A (pt) Composto, processo para a preparação de um composto, composição farmacêutica que compreende um composto, utilização desse composto e processo para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade
AP2088A (en) Phenethanolamine derivatives for treatment of respiratory diseases
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
WO2004037768A3 (en) Phenethanolamine derivatives
IL164373A (en) Benzamide derivatives, pharmaceutical compositions containing them, process for their preparation and use thereof in the manufacture of medicaments and as medicaments in the treatment of diseases associated with cancer
NO20063047L (no) Vandige ciclesonidsuspensjoner for forstoving
BR0110486A (pt) Antranilamidas e sua aplicação como medicamento
WO2004037807A3 (en) Medicinal arylethanolamine compounds
BR0211450A (pt) Método terapêutico
MXPA04002405A (es) Derivados de fenetanolamina para tratamiento de enfermedades respiratorias.
BR0116201A (pt) Composto, processo para a preparação de um composto, composição farmacêutica que compreende o composto, utilização do composto, processo para o tratamento e profilaxia de distúrbios e para o tratamento de obesidade
BRPI0510664B8 (pt) derivados de fenol e tiofenol 3 ou 4-monosubstituído, composição farmacêutica, combinação e uso dos compostos para tratamento de doenças relacionadas ao h3, incluindo transtornos do sistema nervoso central e transtornos inflamatórios
ME00354B (me) Novi lekovi za tretiranje hronićnog opstruktivnog oboljenja pluća
WO2004037773A8 (en) Phenethanolamine derivative for the treatment of respiratory diseases
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
ATE381535T1 (de) Phenethanolaminderivate
LV12632A (lv) Pyrazoline derivatives their preparation and application as medicaments
ES2187300A1 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
HN2005000255A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
MEP42908A (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A., 7A., E 8A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010.